Location: Wilmington
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Wilmington
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring Phase N/A · PPD · Phathom Pharmaceuticals, Inc. · NCT06660342 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi Phase 2 · Novant Health New Hanover Regional Medical Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G Phase 1/Phase 2 · Alfred I duPont Hospital for Children · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · Alfred I duPont Hospital for Children · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Christiana Care Health System-Wilmington Hospital · NRG Oncology · NCT05624996 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Phase 3 · Nemours Alfred I. Dupont Hospital for Children · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Phase 2 · Alfred I duPont Hospital for Children · Children's Oncology Group · NCT06368817 A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During P Phase N/A · Syneos Health · BioMarin Pharmaceutical · NCT05579548 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Phase 2/Phase 3 · Alfred I duPont Hospital for Children · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Family Practice Associates · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Phase 2 · Wilmington Health, PLLC · Eli Lilly and Company · NCT07415044 A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar Phase 3 · Wilmington Dermatology Center /ID# 256192 · AbbVie · NCT07207369 Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation Phase N/A · Research Site · BioDelivery Sciences International · NCT03720613 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer NA · Alfred I duPont Hospital for Children · Alliance for Clinical Trials in Oncology · NCT07091617 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child Phase 3 · Nemours Children's Hospital - Delaware - Cardiology · Bayer · NCT07192952 Quality of Pediatric Resuscitation in a Multicenter Collaborative Phase N/A · Nemours Children's Hospital · Children's Hospital of Philadelphia · NCT02708134 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · Alfred I duPont Hospital for Children · Children's Oncology Group · NCT04322318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer Phase 3 · Christiana Care Health System-Wilmington Hospital · NRG Oncology · NCT05946213 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca Phase N/A · Alfred I. DuPont Hospital for Children · Duke University · NCT04278404 Advancing Transplantation Outcomes in Children Phase 2 · Nemours Children's Health (Site #: 71042) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06055608 A Socio-ecological Approach for Improving Self-management in Adolescents With SCD NA · Nemours Children's Health · Children's Hospital Medical Center, Cincinnati · NCT06290401 A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple S Phase N/A · BRIUMVI® Pregnancy Registry Virtual Research Coordination Ce · TG Therapeutics, Inc. · NCT06433765 A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact Phase 4 · Nemours Children's Hospital · Nemours Children's Clinic · NCT07552766 Tezspire Cardiac Events PASS Phase N/A · Healthcare Integrated Research Database (HIRD) · AstraZeneca · NCT06951867 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · Christiana Care Health System-Wilmington Hospital · Alliance for Clinical Trials in Oncology · NCT06632327 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca Phase 3 · Accellacare Research of Wilmington · Amgen · NCT07575399 A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee Phase 2 · M3 Wake Research - Wilmington, NC · Pacira Pharmaceuticals, Inc · NCT06884865 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Christiana Care Health System-Wilmington Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk Phase N/A · PROVIDE Virtual Research Coordination Center · TG Therapeutics, Inc. · NCT06143514 A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients Phase 2 · Carolina Arthritis Associates - Cliniverse Research (Network · Elevara Medicines Limited · NCT07409103
Look up another city
Look up another condition